Literature DB >> 20153924

The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells.

Jingxuan Pan1, Chao Cheng, Srdan Verstovsek, Qi Chen, Yanli Jin, Qi Cao.   

Abstract

Despite improvements in both surgical techniques and radio- and chemo-therapy regimens, the prognosis of esophageal cancer is poor. In pursuit of novel effective strategy, this study examined the effect of the BH3-mimetic GX15-070 on esophageal carcinoma cells. We discovered that GX15-070 inhibited the growth of esophageal cancer cells. There was synergism between GX15-070 and carboplatin or 5-fluorouracil. GX15-070 induced autophagy in esophagus cancer cell line EC9706 and osteosarcoma cancer cell line U2OS. 3-methyladenine and chloroquine, inhibitors of autophagy with distinct mechanisms, potentiated the cytotoxicity of GX15-070. In conclusion, GX15-070 inhibits growth of esophageal cancer cells. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153924     DOI: 10.1016/j.canlet.2010.01.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  27 in total

1.  Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes.

Authors:  F Basit; S Cristofanon; S Fulda
Journal:  Cell Death Differ       Date:  2013-06-07       Impact factor: 15.828

Review 2.  Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy.

Authors:  S Fulda; D Kögel
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

3.  Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells.

Authors:  Liang Chen; Jingxuan Pan
Journal:  Br J Pharmacol       Date:  2017-06-18       Impact factor: 8.739

Review 4.  Emerging Bcl-2 inhibitors for the treatment of cancer.

Authors:  Asfar S Azmi; Zhiwei Wang; Philip A Philip; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Expert Opin Emerg Drugs       Date:  2010-09-03       Impact factor: 4.191

Review 5.  Autophagy as a cytoprotective mechanism in esophageal squamous cell carcinoma.

Authors:  Timothy M Hall; Marie-Pier Tétreault; Kathryn E Hamilton; Kelly A Whelan
Journal:  Curr Opin Pharmacol       Date:  2018-04-17       Impact factor: 5.547

6.  ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.

Authors:  Yanjie You; Wenjun Yang; Xin Qin; Fei Wang; Haijun Li; Canfeng Lin; Wenmei Li; Cunguo Gu; Yinpo Zhang; Yonggang Ran
Journal:  Cell Oncol (Dordr)       Date:  2015-02-24       Impact factor: 6.730

7.  Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo.

Authors:  Clint Mitchell; Adly Yacoub; Hamed Hossein; Aditi Pandya Martin; M Danielle Bareford; Patrick Eulitt; Chen Yang; Kenneth P Nephew; Paul Dent
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

8.  Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells.

Authors:  Victor Y Yazbeck; Changyou Li; Jennifer R Grandis; Yan Zang; Daniel E Johnson
Journal:  Oral Oncol       Date:  2013-11-08       Impact factor: 5.337

9.  Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.

Authors:  Kazuhito Sasaki; Nelson H Tsuno; Eiji Sunami; Giichiro Tsurita; Kazushige Kawai; Yurai Okaji; Takeshi Nishikawa; Yasutaka Shuno; Kumiko Hongo; Masaya Hiyoshi; Manabu Kaneko; Joji Kitayama; Koki Takahashi; Hirokazu Nagawa
Journal:  BMC Cancer       Date:  2010-07-15       Impact factor: 4.430

Review 10.  Targeting the Bcl-2 family for cancer therapy.

Authors:  Shibu Thomas; Bridget A Quinn; Swadesh K Das; Rupesh Dash; Luni Emdad; Santanu Dasgupta; Xiang-Yang Wang; Paul Dent; John C Reed; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Ther Targets       Date:  2012-11-22       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.